Saga Legal: Ultrahuman $70M Fundraise Successfully Closes

• Ultrahuman, a healthtech company, successfully raised $70 million in a funding round led by Qualcomm Ventures.
• Saga Legal advised Ultrahuman on all legal aspects of the transaction, including documentation, negotiations, and execution.
• The legal teams involved included Neeraj Vyas from Saga Legal and Abhilasha Bhatnagar from Ultrahuman's in-house counsel.
• The new capital will fund Ultrahuman's research and development in sensing technologies, AI, and miniaturized electronics.
• Ultrahuman plans to expand its Blood Vision blood-testing and M1 continuous glucose monitoring platforms globally.

Saga Legal played a pivotal role in advising Ultrahuman throughout the complex fundraising process.

Ultrahuman, a prominent healthtech innovator, has successfully closed a significant funding round, securing $70 million in capital. This substantial investment was spearheaded by Qualcomm Ventures, with additional participation from a consortium of notable investors including Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital, alongside other undisclosed backers. The successful completion of this Ultrahuman $70 million funding legal transaction underscores growing investor confidence in the digital health sector.

Saga Legal played a pivotal role in advising Ultrahuman throughout the complex fundraising process. Their comprehensive legal support encompassed critical aspects such as meticulous documentation, strategic negotiations, and the precise execution of the investment agreements. The firm's involvement extended through the entire transaction process, culminating in its successful closing.

This intricate deal saw close collaboration between Saga Legal's external counsel and Ultrahuman’s dedicated in-house legal department. The Saga Legal team was led by Partner Neeraj Vyas, supported by Senior Associate Ayush Maheshwari and Senior Associate Mehak Chadha. On Ultrahuman's side, the in-house legal team was spearheaded by General Counsel Abhilasha Bhatnagar, with significant contributions from Shashank Sharma (whose current role at Ultrahuman is not publicly available), highlighting the integrated legal effort required for such a substantial Ultrahuman transaction.

Founded by Mohit Kumar and Vatsal Singhal, Ultrahuman has established itself as a leader in the healthtech space, particularly recognized for its innovative smart ring and comprehensive health intelligence ecosystem. The newly acquired capital is earmarked for strategic investments aimed at advancing the company's core technological capabilities and expanding its market reach.

A significant portion of the $70 million fundraise will be channeled into intensive research and development initiatives. These efforts will focus on cutting-edge sensing technologies, advancements in artificial intelligence, the development of miniaturized electronics, and the refinement of sophisticated health algorithms. This commitment to R&D is central to Ultrahuman's mission to enhance its product offerings and maintain its competitive edge.

Furthermore, the funding will facilitate Ultrahuman's ambitious global expansion plans. The company intends to broaden the availability of its Blood Vision blood-testing offering and its M1 continuous glucose monitoring platform across international markets. This expansion underscores Ultrahuman's vision to make its advanced health monitoring solutions accessible to a wider global audience.

The successful completion of this Saga Legal healthtech deal India serves as a notable example of the specialized legal expertise required for high-value transactions within the rapidly evolving health technology landscape. Saga Legal's comprehensive advisory role, from initial negotiations to final execution, demonstrates their capability in navigating the complexities inherent in significant venture capital funding rounds for innovative companies.

This particular Ultrahuman $70M fundraise highlights the critical interplay between external legal advisors and internal corporate counsel. The seamless coordination between Saga Legal's team, including Partner Neeraj Vyas, and Ultrahuman's in-house legal department was instrumental in ensuring the smooth progression and successful closure of the investment. This collaborative model is increasingly common in large-scale funding activities within India's burgeoning tech ecosystem.

This deal showcases Saga Legal's expertise in advising healthtech companies on significant fundraising rounds, providing a precedent for firms and in-house counsel navigating complex venture capital transactions in India's growing tech sector. It also highlights the active role of in-house legal teams in managing such large-scale investments.

Source: Original reporting via Bar & Bench